Quest Diagnostics Inc  

(Public, NYSE:DGX)   Watch this stock  
Find more results for DGX
60.08
0.00 (0.00%)
Apr 15 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 50.46 - 64.10
Open     -
Vol / Avg. 0.00/2.67M
Mkt cap 8.67B
P/E 11.18
Div/yield 0.33/2.20
EPS 5.37
Shares 144.26M
Beta 0.66
Inst. own 106%
May 21, 2014
Quest Diagnostics Annual Shareholder Meeting - 10:30AM EDT - Add to calendar
Apr 24, 2014
Q1 2014 Quest Diagnostics Earnings Release - 9:30AM EDT - Add to calendar
Apr 24, 2014
Q1 2014 Quest Diagnostics Earnings Conference Call - 8:30AM EDT - Add to calendar
Feb 25, 2014
Quest Diagnostics at RBC Capital Markets Healthcare Conference - Webcast
Jan 30, 2014
Q4 2013 Quest Diagnostics Earnings Release
Jan 30, 2014
Q4 2013 Quest Diagnostics Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 8.62% 11.87%
Operating margin 15.36% 20.64%
EBITD margin - 19.59%
Return on average assets 6.79% 9.30%
Return on average equity 14.67% 20.00%
Employees 41,000 -
CDP Score - 59 D

Address

3 Giralda Farms
MADISON, NJ 07940
United States - Map
+1-973-5202700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Quest Diagnostics Incorporated (Quest Diagnostics), is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. Quest Diagnostics offers United States patients and physicians the access to diagnostic testing services through its nationwide network of laboratories and Company-owned patient service centers. It provides interpretive consultation through the medical and scientific staff. It is a provider of clinical testing, including gene-based and esoteric testing and anatomic pathology services, and the provider of risk assessment services for the life insurance industry. In October 2013, Quest Diagnostics Incorporated acquired ConVerge Diagnostic Services, LLC from Water Street Healthcare Partners. In March 2014, the Company acquired Solstas Lab Partners Group and its subsidiaries.

Officers and directors

Stephen H. Rusckowski President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Mark J. Guinan Chief Financial Officer, Senior Vice President
Age: 50
Bio & Compensation  - Reuters
Lidia L. Fonseca Senior Vice President, Chief Information Officer
Age: 44
Bio & Compensation  - Reuters
Michael E. Prevoznik Senior Vice President, General Counsel
Age: 51
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jon Roger Cohen M.D. Senior Vice President, Chief Medical Officer
Age: 58
Bio & Compensation  - Reuters
Everett V. Cunningham Senior Vice President - Commercial
Age: 46
Bio & Compensation  - Reuters
James E. Davis Senior Vice President - Operations
Bio & Compensation  - Reuters
Catherine T. Doherty Senior Vice President - Clinical Franchises
Age: 50
Bio & Compensation  - Reuters
Daniel C. Stanzione Ph.D. Non-Executive Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Timothy L. Main Director
Age: 56
Bio & Compensation  - Reuters